Key Highlights

  • Cognyte Software Ltd (Nasdaq (ticker CGNT):CGNT) said an existing military intelligence customer in the Asia-Pacific had expanded its deployment under a contract worth about US$15 million, embedding its analytics platform in border-security command centres.
  • In the first quarter of fiscal 2027, the three months, reported on 3 June, revenue was US$105.5 million, up 10.4%.
  • The demand backdrop does much of the work. Governments face more data, faster-moving adversaries and pressure to act on both, and Cognyte sells to agencies that already trust it.
  • Adjusted EBITDA of US$13.6 million in the April quarter sat alongside a US$3.0 million statutory net loss, and fiscal 2026 produced a small loss despite 14% revenue growth.

Why the market is paying attention

Cognyte Software Ltd (Nasdaq (ticker CGNT):CGNT) said an existing military intelligence customer in the Asia-Pacific had expanded its deployment under a contract worth about US$15 million, embedding its analytics platform in border-security command centres. It was the eighth contract announcement the company has issued since late February.

The shares have not followed. Cognyte Software trades against a 52-week range of US$6.29 to US$12.31, near the bottom of that range even as orders accumulate.

What the company does

Cognyte sells investigative analytics: software that ingests very large volumes of data, communications metadata, open-source and social media material, network traffic and the customer's own records, and turns it into leads and evidence. Buyers are national security agencies, military intelligence units and law enforcement bodies.

Spun out of Verint Systems in early 2021 and headquartered in Israel, it has a 31 January year end, so fiscal 2026 closed. Revenue splits between software, software-related services including subscription, and lower-margin professional services. Almost every sale requires an export licence.

Latest financial and operating performance

In the first quarter of fiscal 2027, the three months, reported on 3 June, revenue was US$105.5 million, up 10.4%. Software revenue rose 26.5% to US$47.3 million and software-related services 12.1% to US$50.1 million, while lower-margin professional services fell to US$8.2 million.

Statutory gross margin was 72.4% and operating income doubled to US$4.4 million, but the net loss attributable to Cognyte widened to US$3.0 million, or US$0.04 a share. On the adjusted basis management prefers, which excludes share-based compensation, adjusted EBITDA was US$13.6 million, up 31.5%.

Recurring revenue reached US$51.9 million, 49.2% of the total. Remaining performance obligations, contracted revenue not yet recognised, were US$528.8 million, with backlog of US$399.8 million. Cognyte held US$109.2 million of cash and no debt; operating cash flow was an outflow of US$4.7 million in a seasonally weak quarter.

Fiscal 2026 revenue was US$400.0 million, up 14.1%, with adjusted EBITDA of US$48.2 million, up 66%, operating cash flow of US$40.3 million and a statutory net loss of US$0.6 million. Fiscal 2027 guidance is revenue of about US$448 million plus or minus 3%, adjusted EBITDA near US$68 million and non-GAAP earnings of US$0.47 a share.

The catalyst that matters: a steady drumbeat of contract news

Cognyte has published a contract announcement roughly every five weeks this year: a US$5 million follow-on order from a NATO member's military in February, an expansion worth more than US$10 million with a tier-one national security agency in March, a three-year subscription worth more than US$20 million with a European customer in April, and July's US$15 million Asia-Pacific expansion. The announced values total at least US$70 million.

The significance lies less in the sums, even US$15 million is barely 3% of guided annual revenue, than in their character. Most are expansions with agencies already running the platform, and several are subscriptions rather than perpetual licences, which spreads revenue over time instead of recognising it up front.

Timing matters. Remaining performance obligations fell from US$557.2 million at the January year end to US$528.8 million at 30 April, and backlog from US$433.4 million to US$399.8 million. The wins announced from late April are not yet in those figures, making the second quarter the first real test.

The bull case

The demand backdrop does much of the work. Governments face more data, faster-moving adversaries and pressure to act on both, and Cognyte sells to agencies that already trust it.

The operating leverage is real: guidance implies roughly 12% revenue growth producing about 40% growth in adjusted EBITDA, after that measure rose 66% in fiscal 2026. The balance sheet supports patience, with US$109.2 million of cash, no debt and about US$35 million of a US$60 million buyback used since November 2024.

The United States is close to a blank page. Chief executive Elad Sharon has pointed to roughly US$20 million of US business this year, and Adam Philpott, formerly of Trellix, becomes chief revenue officer.

The bear case and the risks

Still loss-making where it counts. Adjusted EBITDA of US$13.6 million in the April quarter sat alongside a US$3.0 million statutory net loss, and fiscal 2026 produced a small loss despite 14% revenue growth. The gap is largely share-based compensation, a real cost through dilution even when added back.

Concentration. The annual report for the year discloses that one government customer accounted for about 18% of revenue; in earlier years two customers together represented 28% to 30%.

Export licensing. Cognyte depends on export and marketing approvals from government agencies, and its own disclosures state that such approvals have been revoked in the past for reasons beyond its control, including political and geopolitical ones.

Human rights scrutiny. This is not hypothetical. Meta's December 2021 threat report on the surveillance-for-hire industry named Cognyte among seven entities it acted against, removing about 100 associated accounts, and said targets included journalists and politicians across nine countries. Cognyte's own filings acknowledge heightened scrutiny from privacy advocates, NGOs, politicians and media, and allegations of misuse by customers perceived as violating human rights.

Announcement-driven visibility. Deal releases are not audited bookings, the values are approximate and revenue recognition timing is not disclosed.

What investors should watch next

Second-quarter results. The quarter ended is the first to capture the recent contract flow; aggregated market data lists an expected reporting date of, unconfirmed by the company.

Order metrics. Whether remaining performance obligations and backlog recover past the year-end levels of US$557.2 million and US$433.4 million.

Recurring revenue. It reached 49.2% of sales in April; a move above half, with revenue still tracking guidance, would show the model shift is not costing growth.

United States progress. The roughly US$20 million of US business flagged for this year is small but checkable.

Cash conversion. Guidance calls for about US$45 million of operating cash flow after a negative first quarter, with roughly US$25 million of the buyback authorisation unused.

Investor takeaway

Cognyte is a genuinely improving business rather than a transformed one. Revenue grew 14.1% in fiscal 2026 and 10.4% in the April quarter, adjusted profitability is compounding faster than sales, the balance sheet carries US$109.2 million of cash and no debt, and contract news has been steady since February.

Against that, the statutory accounts still show losses, one government customer supplies about 18% of revenue, order metrics dipped sequentially in April, and the human rights and export licensing questions attached to this industry are permanent features rather than passing controversies. The breakout thesis deserves a question mark: guidance points to about 12% growth, solid rather than explosive. What the September report does to backlog will matter more than any press release.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.